Long-term chronic infection of a young immunocompromised patient by the SARS-CoV-2 P.2 VOI
2024

Long-term SARS-CoV-2 Infection in an Immunocompromised Patient

Sample size: 1 publication Evidence: moderate

Author Information

Author(s): Romano Camila Malta, da Silva Vitor Gabriel Lopes, da Silva Luciane Sussuchi, Aranda Carolina Sanchez, de Oliveira Cristina Mendes, Siqueira Marilda Mendonça Teixeira, Pereira Elisa Cavalcante, Resende Paola Cristina, Bellei Nancy Cristina Junqueira, Levi José Eduardo, de Moraes-Pinto Maria Isabel

Primary Institution: Universidade de São Paulo, Faculdade de Medicina, Instituto de Medicina Tropical de São Paulo

Hypothesis

Can chronic SARS-CoV-2 infections in immunocompromised individuals lead to significant viral evolution?

Conclusion

The study highlights that immunocompromised individuals can harbor SARS-CoV-2 for extended periods, leading to accelerated viral evolution.

Supporting Evidence

  • The patient was infected with SARS-CoV-2 for 431 days, the longest documented case of Zeta (P.2) persistence.
  • The virus accumulated 23 mutations during the infection period.
  • High D-dimer levels and pulmonary complications were observed during hospitalization.
  • The patient received three doses of the Pfizer-BioNTech vaccine but continued to experience symptoms.

Takeaway

This study shows that a sick person with a weak immune system can keep the same virus for a long time, and during that time, the virus can change a lot.

Methodology

The study involved collecting six naso-oropharyngeal swabs for SARS-CoV-2 RT-PCR testing and whole genome sequencing at different times during the infection.

Limitations

The study lacks intermediate samples for a deeper understanding of intra-host viral evolution.

Participant Demographics

A 17-year-old Brazilian male with X-linked agammaglobulinemia.

Digital Object Identifier (DOI)

10.1590/S1678-9946202466069

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication